ABC | Volume 114, Nº5, May 2020

Statement Brazilian Cardiology Society Statement for Management of Pregnancy and Family Planning in Women with Heart Disease – 2020 Arq Bras Cardiol. 2020; 114(5):849-942 267. BrownMA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al.Thehypertensivedisordersofpregnancy: ISSHPclassification,diagnosis andmanagement recommendations for international practice. Pregnancy Hypertens. Hypertension. 2018;72(1):24-43. 268. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force onClinical PracticeGuidelines. J AmColl Cardiol. 2018;71(19):e127-248. 269. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122-31. 270. Sociedade Brasileira de Cardiologia. Guidelines for pregnancy in the womanwith heart disease. ArqBras Cardiol. 2009;93(6 Suppl 1):e110-78. 271. Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129(11):1254-61. 272. ScantleburyDC,SchwartzGL,AcquahLA,WhiteWM,MoserM,GarovicVD. The Treatment of Hypertension During Pregnancy: When Should Blood PressureMedications Be Started? Curr Cardiol Rep. 2013;15(11):412. 273. Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301 274. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database Syst Rev. 2005 Oct;(4):CD003514. 275. Report of the National High Blood Pressure Education ProgramWorking Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-22. 276. Committee on Obstetric Practice. Committee on Obstetric Practice. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2015;125(2):521-5. 277. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38. 278. National Institute for Health and Clinical Excellence (NICE). Hypertension in pregnancy. London:RCOG Press; 2011. (NICE clinical guideline 107) 279. Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, et al. Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Can J Cardiol. 2018;34(5):526-31. 280. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012;119(2 Pt 1):396-407. 281. de Paola AAV, Montenegro S, Vieira MC. Livro-texto da Sociedade Brasileira de Cardiologia. 2ª ed. São Paulo:Ed Manole;2015. Cap.27. 282. Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12(12):718-29. 283. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014 Feb;(2):CD002252. 284. Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(5):407-17. 285. Magee LA, vonDadelszen P, Singer J, Lee T, Rey E, Ross S, et al. The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): is severe hypertension just an elevated blood pressure? Hypertension. 2016;68(5):1153-9. 286. Fitton CA, Steiner MF, Aucott L, Pell JP, Mackay DF, Fleming M, et al. In- utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review. J Hypertens. 2017;35(11):2123-37. 287. Ramakrishnan A, Lee LJ, Mitchell LE, Agopian AJ. Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis. Pediatr Cardiol. 2015;36(7):1442-51. 288. Fisher SC, Van Zutphen AR,Werler MM, Lin AE, Romitti PA, Druschel CM, et al. Maternal Antihypertensive Medication Use and Congenital Heart Defects: Updated Results From the National Birth Defects Prevention Study. Hypertension. 2017;69(5):798-805. 289. Food and Drug Administration (FDA). Pregnancy, lactation, and reproductive potential: labeling for human Prescription drug and biological products. Fed Regist.2014;79(233):72063-103. 290. Shimada C, Akaishi R, Cho K, Morikawa M, Kaneshi Y, Yamda T, et al. Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review. Hypertens Res. 2015;38(5):308-13. 291. Magee LA, Duley L. Oral beta-blockers for mild tomoderate hypertension during pregnancy. Cochrane Database Syst Rev. 2003 Jul;(3):CD002863. 292. Ersbøll AS, Hedegaard M, Søndergaard L, Ersbøll M, Johansen M. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG. 2014;121(5):618-26. 293. Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol (Copenh). 1980;95(4):540-5. 294. EasterlingTR.Pharmacologicalmanagementofhypertension inpregnancy. Semin Perinatol. 2014;38(8):487-95. 295. Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs. 2014;74(3):283-96. 296. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51(4):960-9. 297. Ahn HK, Nava-Ocampo AA, Han JY, et al. Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding. Hypertens Pregnancy. 2007;26(2):179-87. 298. Ramos JG, Sass N, Costa SH. Preeclampsia. Rev Bras Ginecol Obstet. 2017;39(9):496-512. 299. Brasil.Ministério da Educação. Porta lEbserh/; MEAC-UFC. Maternidade escola Assis Chateaubriand daUniversidade Federal do Ceará. Protocolos e diretrizes terapêuticas.[Internet}. [Citado em 2018 jan 10]. Disponível em: www.ebserh.gov.br/web/meac-ufc/protocoços-e-pops 300. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006 Jul;(3):CD001449. 301. Swartz RH, Cayley ML, Foley N, Ladhani NN, Leffert L, Bushnell C, et al. The incidence of pregnancy related stroke: a systematic review andmeta- analysis. Int J Stroke. 2017;12(7):687-97. 302. Okusanya BO, Oladapo OT, Long Q, Lumbiganon P, Carroli G, Qureshi Z, et al. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG. 2016;123(3):356-66. 303. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;(11):CD000025. 937